The Impact of Radiotherapy on Complications and Reconstruction Failures in Patients Undergoing Mastectomy and Breast Reconstruction
L. Zhang,X. Wang,K. Jin,Z. Yang,X. Chen,J. Wu,Z. Shao,X. Yu,X. M. Guo
DOI: https://doi.org/10.1016/j.ijrobp.2019.06.2405
2019-01-01
Abstract:This study was designed to determine the impact of postmastectomy radiotherapy (PMRT) on complications and reconstruction failures in women undergoing mastectomy and breast reconstruction. We retrospectively identified 832 breast cancer patients who underwent mastectomy and breast reconstruction at our institution between June 2001 and December 2015. Of these, 159 patients received PMRT and 673 patients did not receive PMRT. Information on complications and reconstruction failures were collected from electronic medical records and/or telephone follow-up. The endpoints included any complication, major complication, overall reconstruction failure, and complication-related reconstruction failure. Multivariable logistic regression models were used to evaluate the impact of PMRT on complications and reconstruction failures according to different breast reconstruction types after adjusting for relevant covariates. The median follow-up time was 58.5 months. Of all 832 patients, 394 patients received implant-based reconstruction and 438 patients received autologous reconstruction. The rates of any complications, major complications, overall reconstruction failures and complication-related reconstruction failures in patients with implant-based reconstruction were 23.6%, 5.8%, 7.1% and 4.6%, respectively, and 17.4%, 5.0%, 2.1% and 1.6, respectively, in patients with autologous reconstruction. For patients with implant-based reconstruction, multivariable analysis showed that PMRT was associated with 3.23 times (95%CI 1.20-8.72, p=0.021) higher odds of major complications and 3.31 times (95%CI 1.04-10.53, p=0.042) higher odds of complication-related reconstruction failures, but not associated with any complications (OR 1.72, 95%CI 0.88-3.37, p=0.115) and overall reconstruction failures (OR 2.15, 95%CI 0.78-5.89, p=0.139). For patients with autologous reconstruction, multivariable analysis showed that PMRT was not associated with any complications (OR 1.27, 95%CI 0.71-2.27, p=0.431), major complications (OR 1.11, 95%CI 0.39-3.13, p=0.844), overall reconstruction failures (OR 1.29, 95%CI 0.28-5.36, p=0.742) and reconstruction-related reconstruction failures (OR 2.20, 95%CI 0.41-11.77, p=0.358). PMRT appears to be associated with an increased risk of major complications and complication-related reconstruction failures in patients with implant-based reconstruction. Large prospective studies are needed to further confirm this finding.